RealTime eClinical Solutions is a prominent provider of eClinical technology solutions designed to streamline clinical trials. The company offers a comprehensive suite of products that cater to various stakeholders in the clinical research industry, including research sites, site networks, academic medical centers, sponsors, and Contract Research Organizations (CROs). The platform integrates tools such as Clinical Trial Management Systems (CTMS), eSource, and eRegulatory/eISF, enhancing efficiency and compliance in clinical trials.

RealTime eClinical Solutions was founded in 2012, emerging from a division of the technology and consulting leader Eliassen Group. The company was established to address the growing challenges in clinical data management by leveraging cloud and digital platforms. Over the years, RealTime has expanded its operations globally, including opening an office in Bangalore, India, to support increasing demand and global operations.

RealTime eClinical Solutions received a significant growth equity investment from Summit Partners in January 2020, amounting to $19.25 million. This funding was aimed at supporting the expansion of their cloud-based Clinical Data Hub platform, elluminate®, and associated data services. The investment reflects the company's strong market position and the growing demand for its solutions in the life sciences sector.

The company's flagship product, the elluminate® platform, serves as a Clinical Data Hub that integrates and unifies clinical data sources, providing real-time visibility and analytics. This platform is designed to empower life sciences organizations by offering a holistic view of clinical data, facilitating better decision-making and accelerating the clinical development process. RealTime's solutions are known for their flexibility, allowing users to tailor features to their specific needs, which enhances operational efficiency and compliance.

RealTime eClinical Solutions has focused on expanding its product offerings through strategic partnerships and technological innovations. The company has integrated advanced features into its platform, such as real-time data access and enhanced collaboration tools, to meet the evolving needs of the clinical research industry. These efforts have positioned RealTime as a leader in providing comprehensive eClinical solutions.

The company continuously innovates by adding new features to its platform, such as enhanced data analytics and real-time data integration capabilities. These features are designed to improve the efficiency of clinical trials and provide users with greater control over their data. RealTime's commitment to innovation ensures that its platform remains at the forefront of the industry.

RealTime eClinical Solutions is driven by a mission to accelerate the clinical development process and bring new treatments to patients faster. The company values innovation, collaboration, and customer satisfaction, which are reflected in its commitment to providing cutting-edge technology solutions and exceptional customer support. RealTime's culture emphasizes continuous improvement and adapting to the changing needs of the clinical research industry.

RealTime eClinical Solutions serves a diverse user base, including more than 100 life sciences organizations. The company's platform has been used in over 500 clinical trials, highlighting its widespread adoption and effectiveness in the industry. RealTime's user community benefits from the platform's robust features and the company's dedication to supporting clinical research across various therapeutic areas and phases.